Infections: Clinical Trials

28 trials for Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 suspended. 28 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 328Suspended 28
Phase 28Suspended 8

Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BCG Revaccination in Children and Adolescents
BCG vaccine, Oral Chemoprophylaxis - Tuberculosis Infection, Tuberculosis
Phase 3SuspendedTuberculosis Research Centre, India92002024-07-152023-12-18
Extracorporal Cytokin Removal in Septic Shock: a Prospective, Randomized, Multicenter Clinical Trial
Standard medical therapy, Standard medical therapy plus cytokine removal treatment using Cytosorb, with the adsorber changed in every 12 hours, Standard medical therapy plus cytokine removal treatment using Cytosorb, with the adsorber changed in every 24 hours - Septic Shock
Phase 3SuspendedUniversity of Pecs1352024-01-012023-04-20
Tecovirimat in Non-hospitalized Patients With Monkeypox
Tecovirimat, Placebo - Monkeypox
Phase 3SuspendedMarina Klein1202023-08-142026-03-04
Intracameral Antibiotic Safety Study
Vancomycin, Moxifloxacin, Placebo - Intracameral Antibiotics, Cataract Surgery
Phase 3SuspendedPanhandle Eye Group, LLP5002023-01-012022-04-27
Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
RESP301 - Pulmonary Complications in Surgical Patients, COVID
Phase 3SuspendedUniversity of Birmingham64002022-05-162025-02-20
Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients
Fludrocortisone, Placebo - Septic Shock
Phase 2 / Phase 3SuspendedRennes University Hospital402022-03-312023-11-18
Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
Yinhu Qingwen Granula, Yin Hu Qing Wen Granula(low does), standard medical treatment - COVID-19, Severe Pneumonia
Phase 2 / Phase 3SuspendedZhong Wang1162021-11-012021-07-07
Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation
Leronlimab, Placebo - COVID-19 Pneumonia
Phase 3SuspendedHospital Israelita Albert Einstein3162021-10-232022-04-15
Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19
YinHu QingWen Decoction, YinHu QingWen Decoction(low dose), Chinese medicine treatment - CoVID-19, Chinese Medicine
Phase 2 / Phase 3SuspendedChina Academy of Chinese Medical Sciences3002021-10-012021-07-07
Leronlimab in Moderately Ill Patients With COVID-19 Pneumonia
Leronlimab, Placebo - COVID-19 Pneumonia
Phase 3SuspendedHospital Israelita Albert Einstein6122021-09-092022-04-15
CBD Oil for Reducing Emotional Impact of COVID-19
CBD Isolate, Full Spectrum CBD Oil, Broad-Spectrum CBD Oil - Anxiety Depression, Alcohol Abuse
Phase 2 / Phase 3SuspendedUniversity of Texas at Austin2002020-12-042023-11-22
Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu
Desloratadine+Phenylephrine+Ibuprofen, Placebo - Cold
Phase 3SuspendedAche Laboratorios Farmaceuticos S.A.1502020-12-012019-07-08
Measles Vaccine in HCW
Measles-Mumps-Rubella Vaccine, Placebos - Covid19
Phase 3SuspendedKasr El Aini Hospital2002020-07-132020-12-22
VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)
Hydroxychloroquine, Azithromycin, Placebo oral tablet - SARS-CoV-2, COVID-19
Phase 3SuspendedSalomeh Keyhani MD3002020-04-302020-06-22
Proactive Care of Ambulatory COVID19 Patients
consultation, Azithromycin - Covid19, Azithromycin
Phase 3SuspendedCentre Hospitalier Universitaire, Amiens112020-04-292023-03-21
Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO
Sarilumab, Azithromycin, Hydroxychloroquine - COVID19, SARS-CoV-2 Infection
Phase 2 / Phase 3SuspendedAssistance Publique - Hôpitaux de Paris272020-04-112020-05-06
A Trial of Remdesivir in Adults With Mild and Moderate COVID-19
Remdesivir, Remdesivir placebo - COVID-19, SARS-CoV-2
Phase 3SuspendedCapital Medical University3082020-02-122020-04-15
Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults
MMH-407, Placebo - Influenza
Phase 3SuspendedMateria Medica Holding3142019-12-122023-08-18
Angiotensin II for Septic Shock Treatment
Angiotensin II, Normal saline, Norepinephrine - Septic Shock
Phase 3SuspendedCairo University202019-04-012019-01-16
Effectiveness of Fecal Flora Alteration for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization
Fecal Microbiota Transplantation (FMT) - Infection
Phase 2 / Phase 3SuspendedSusy Hota402019-03-222022-11-03

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

COVID-19 (11)  ·  Influenza, Human (4)  ·  Pneumonia (4)  ·  Sepsis (3)  ·  Shock, Septic (3)  ·  HIV Infections (2)  ·  Alcoholism (1)  ·  Clostridium Infections (1)  ·  Common Cold (1)  ·  Diarrhea (1)  ·  Endophthalmitis (1)  ·  Fever (1)  ·  Fractures, Stress (1)  ·  Latent Tuberculosis (1)

Broader conditions

Virus Diseases (18)  ·  RNA Virus Infections (17)  ·  Respiratory Tract Diseases (15)  ·  Respiratory Tract Infections (15)  ·  Coronaviridae Infections (11)  ·  Coronavirus Infections (11)  ·  Lung Diseases (11)  ·  Nidovirales Infections (11)  ·  Pneumonia, Viral (11)  ·  Pneumonia (7)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Inflammation (5)  ·  Pathologic Processes (5)  ·  Systemic Inflammatory Response Syndrome (5)

Interventions

Azithromycin (3)  ·  Hydroxychloroquine (2)  ·  leronlimab (2)  ·  Acetaminophen (1)  ·  Angiotensin II (1)  ·  BCG Vaccine (1)  ·  Chemoprevention (1)  ·  Chloroquine (1)  ·  Dehydroepiandrosterone (1)  ·  Dipyrone (1)  ·  Emtricitabine (1)  ·  Fecal Microbiota Transplantation (1)  ·  Fludrocortisone (1)  ·  Measles-Mumps-Rubella Vaccine (1)  ·  Moxifloxacin (1)

Sponsors

Hospital Israelita Albert Einstein (2)  ·  Nanogen, Inc. (2)  ·  Ache Laboratorios Farmaceuticos S.A. (1)  ·  Agennix (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Barzilai Medical Center (1)  ·  Bio-K Plus International Inc. (1)  ·  Cairo University (1)  ·  Capital Medical University (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  China Academy of Chinese Medical Sciences (1)  ·  Hospital Clinic of Barcelona (1)  ·  Kasr El Aini Hospital (1)  ·  Marina Klein (1)  ·  Materia Medica Holding (1)

Countries

United States (8)  ·  France (4)  ·  Brazil (3)  ·  Canada (3)  ·  China (3)  ·  Egypt (2)  ·  Israel (2)  ·  Spain (2)  ·  Belgium (1)  ·  Cameroon (1)  ·  Denmark (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Hungary (1)  ·  India (1)

Top investigators

Jiang-Rong Huang, M.D. (2)  ·  Xiao-Dong Li, M.D. (2)  ·  Ahmed Mukhtar, Professor (1)  ·  Aishwarya Venkataraman, MRCPCH (1)  ·  Albert Grinshpun (1)  ·  Aneel Bhangu (1)  ·  Bruno Laviolle, MD, PhD (1)  ·  Cornelius J Foley, MD (1)  ·  Dong Shang, M.D. (1)  ·  Felipe Garcia, MD, PhD (1)  ·  Harmonie Perrichet, MD (1)  ·  Jean-Philippe Lanoix, Pr (1)  ·  Mauro Crippa Jr. (1)  ·  Michael J Telch, Ph.D. (1)

Results publications

PMID 26010687, PMID 34011199, PMID 34350582, PMID 34446497, PMID 34473343, PMID 36695483